The interaction of FEV1 and NT-Pro-BNP with outcomes after transcatheter aortic valve replacement Feb. 27, 2023 Overview Show transcript Overview Juan A. Crestanello, M.D., is a cardiovascular surgeon and department chair of Cardiovascular Surgery at Mayo Clinic in Rochester, Minnesota. Dr. Crestanello, who specializes in surgery for valvular heart disease, discusses the interaction of FEV1 and NT-Pro-BNP with outcomes after transcatheter aortic valve replacement. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up VID-20550092 Medical Professionals The interaction of FEV1 and NT-Pro-BNP with outcomes after transcatheter aortic valve replacement